Roy D. Baynes Travere Therapeutics, Inc. (TVTX) insider trading activity

TVTX Quotes by TradingView

Roy D. Baynes is of Travere Therapeutics, Inc.. Currently has a direct ownership of 31,000 shares of TVTX, which is worth approximately $565,750. The most recent transaction as insider was on May 08, 2024, when has been sold 6,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31K
0% 3M change
26.53% 12M change
Total Value Held $565,750

Roy D. Baynes Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2024
BUY
Grant, award, or other acquisition
-
6,500 Added 17.33%
31,000 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
-
4,500 Added 15.52%
24,500 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
3,000 Added 13.04%
20,000 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
3,000 Added 15.0%
17,000 Common Stock

Also insider at

NTRA
Natera, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
RDB

Roy D. Baynes

Austin, TX

Track Institutional and Insider Activities on TVTX

Follow Travere Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TVTX shares.

Notify only if

Insider Trading

Get notified when an Travere Therapeutics, Inc. insider buys or sells TVTX shares.

Notify only if

News

Receive news related to Travere Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TVTX